Boardroom Alpha
Start trial
Boardroom Alpha
BR · Additional Proxy Materials (DEFA14A) · Filed September 29, 2026

Broadridge Financial Solutions Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
September 29, 2026
Ticker
BR
Accession
0001140361-26-037938
Broadridge Financial Solutions Inc on Boardroom AlphaView on SEC EDGAR
Boardroom Alpha · Filing insights

Consult the filing for more details.

About Broadridge Financial Solutions Inc
Market cap
$18.4B
1Y TSR
−29.5%
3Y TSR
−1.2%
Board grade
C
Sector
Technology
CEO
Timothy C Gokey
Last annual meeting: Nov 10, 2026 · View full Broadridge Financial Solutions Inc profile →
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a party other than the Registrant  ☐
Check the appropriate box:
 ☐ Preliminary Proxy Statement
 ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐ Definitive Proxy Statement
 ☒ Definitive Additional Materials
 ☐ Soliciting Material under §240.14a-12
BROADRIDGE FINANCIAL SOLUTIONS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☒ No fee required.
 ☐ Fee paid previously with preliminary materials.
 ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
 

 Every Vote Counts  Every vote counts. To express our appreciation for your participation, Broadridge will donate $1 to NPower on behalf of every shareholder account that votes. NPower is a national nonprofit organization dedicated to creating opportunities in the technology sector for young adults and military-connected individuals.  P55202-EPN 
 
 Frequently Asked Questions  Why am I receiving this Notice of Internet Availability?  The Securities and Exchange Commission (“SEC”) permits companies to send the enclosed “Notice” instead of a full printed set of proxy materials. The Notice provides instructions on how to view your company’s proxy materials, vote online and request a full set of printed materials by mail.  There are several advantages to your company sending a Notice instead of a full set of materials, including lowering your company’s costs and reducing the environmental impact from printing and mailing full sets of proxy materials.  How do I view the proxy materials online?  Go to www.ProxyVote.com/BR and enter your control number to get started. Your control number can be found on the enclosed Notice.  What if I prefer to receive a paper copy of the proxy materials?  You can easily request a paper copy which will be mailed to you at no cost. Instructions on how to do so can be found in the "Get informed before you vote" section of the Notice.  Can I receive proxy materials for future meetings by e-mail rather than receive a Notice?  Yes you can. Go to www.ProxyVote.com/BR and make your choice in the Delivery Settings section.  For more information about the SEC’s Notice and Access Proxy Rules please visit: www.sec.gov/spotlight/proxymatters/e-proxy.shtml.  DOCUMENT ID 2/23 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

See Meeting ForecastSchedule a Demo

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Broadridge Financial Solutions Inc (BR)

Continue researching
Reference

Frequently asked questions

When did Broadridge Financial Solutions Inc file this DEFA14A?
Broadridge Financial Solutions Inc (BR) filed this Additional Proxy Materials (DEFA14A) with the SEC on September 29, 2026. The accession number assigned by EDGAR is 0001140361-26-037938.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Consult the filing for more details. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Broadridge Financial Solutions Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Broadridge Financial Solutions Inc has filed under CIK 1383312, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer